| Patents for C07D 261 - Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings (11,459) |
|---|
| 06/07/2005 | US6903221 Reacting arylhalogenide with 1,3-diketone in carbon monoxide atmosphere; herbicides |
| 06/07/2005 | US6903216 Antiarrhythmic agents for the treatment and prophylaxis of atrial arrhythmias, atrial fibrillation (AF) or atrial flutter; potassium channel modulators, beta-blocker |
| 06/07/2005 | US6903215 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 06/07/2005 | US6903128 Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
| 06/07/2005 | CA2281090C Sulfonamide compounds and salts for treatment of endothelin-mediated disorders |
| 06/02/2005 | WO2005049623A1 PREPARATION OF 1-AZA-2-OXA-DIBENZO[e,h]AZULENES AND THEIR USE FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS |
| 06/02/2005 | WO2005049589A2 Heterocyclic compounds for the treatment of hyperlipidemia, diabetes, obesity and similar diseases |
| 06/02/2005 | WO2005049064A1 Drug therapy for celiac sprue |
| 06/02/2005 | WO2005048953A2 Amide derivatives as kinase modulators |
| 06/02/2005 | WO2005048948A2 Urea derivatives as kinase modulators |
| 06/02/2005 | US20050119332 Substituted thiophene compounds as modulators of protein tyrosine phosphatases (PTPases) |
| 06/02/2005 | US20050119225 Phosphodiesterase 4 inhibitors, including N-substituted aniline and diphenylamine analogs |
| 06/02/2005 | CA2546620A1 Preparation of 1-aza-2-oxa-dibenzo[e,h]azulenes and their use for the manufacture of pharmaceutical formulations for the treatment and prevention of central nervous system diseases and disorders |
| 06/02/2005 | CA2545711A1 Urea derivatives as kinase modulators |
| 06/01/2005 | EP1535912A1 Muscarinic agonists |
| 06/01/2005 | EP1535909A2 Cyclic amine derivatives and their use as drugs |
| 06/01/2005 | EP1534696A1 Therapeutic compounds for treating dyslipidemic conditions |
| 06/01/2005 | EP1534693A2 1, 3-diamino-2-hydroxypropane prodrug derivatives |
| 06/01/2005 | EP1534683A2 Cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 06/01/2005 | EP1534666A1 Compounds for modulating the glycolosis enzyme complex and/or transaminase complex |
| 06/01/2005 | EP1534273A2 Modulators of the glucocorticoid receptor and method |
| 06/01/2005 | EP1351959B1 Novel pleuromutilin derivatives |
| 06/01/2005 | EP1345902B1 Substituted heterocyclo-norbornylamine derivatives, method for producing the same, their use as medicament or diagnostic agent and medicament containing the same |
| 06/01/2005 | EP0946499B1 N-(aryl/heteroaryl/alkylacetyl) amino acid amides, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds |
| 06/01/2005 | CN1621404A Drug and method for regulating cholesterol and triglyceride |
| 06/01/2005 | CN1203852C Valdecoxib compositions |
| 05/31/2005 | US6900345 Antibiotics; mutilin 14-[N-(2-carbamoyloxyethoxycarbonyl)]carbamate; therapy for bacteria infections; chemical synthesis |
| 05/31/2005 | US6900334 Antiallergens; autoimmune diseases |
| 05/31/2005 | US6900333 Dissolving in aqueous solution containing alcohols; distillation; purification |
| 05/26/2005 | WO2005047236A1 Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses |
| 05/26/2005 | US20050113440 Compounds that modulate PPAR activity and methods for their preparation |
| 05/26/2005 | US20050113424 E.g., 4-{3-[4-(3-{4-[amino(imino)methyl]phenoxy}propyl)-1-piperazinyl]propoxy}benzamidine; an antifungal agent with good pharmacokinetics and excellent antifungal action; side effect reduction such as nephrotoxicity; action to Mycomycetes |
| 05/26/2005 | US20050113419 Therapeutic compounds for treating dyslipidemic conditions |
| 05/26/2005 | US20050113373 medicine to inhibit proliferative conditions, such as cancer and psoriasis; detecting or identifying a histone deactylase (HDAC) in a biological sample |
| 05/26/2005 | US20050113357 Cholinergic agents such as 3-[3-(4-methoxypiperidine)-1-yl-propyl]-1H-indole; for therapy of cognitive dysfunction, forgetfulness, confusion, memory loss, attention deficits, deficits in visual perception, depression, pain, sleep disorders, and psychosis |
| 05/26/2005 | US20050113356 Inhibitors of cathepsin S |
| 05/26/2005 | US20050112197 Celecoxib dissolving in polyethylene glycol; antiinflammatory agents, osteoporosis, respiratory system disorders, antitumor agents, analgesics |
| 05/25/2005 | EP1533292A1 Dibenzylamine compound and medicinal use thereof |
| 05/25/2005 | EP1531812A1 Fused heteroaryl derivatives for use as p38 kinase inhibitors in the treatment of i.a. rheumatoid arthristis |
| 05/19/2005 | WO2005044808A1 A process for the manufacture of zonisamide |
| 05/19/2005 | WO2005012220A9 Cycloalkylidene compounds as modulators of estrogen receptor |
| 05/19/2005 | US20050107444 E.g., 2-(3-{3-[(2-chloro-3-(trifluoromethyl)-benzyl)-(2,2-diphenylethyl)-amino]-propoxy}phenyl)-1-morpholin-4-yl-ethanone; agonists of the nuclear receptors, LXR alpha and LXR beta used to increase ABCA1, ABCG1, and apolipoprotein E expression and inhibiting cholesterol absorption |
| 05/19/2005 | US20050107435 antibiotics such as (5S,5S')-N-(3-{4'-[5-(Acetylamino-methyl)-2-oxo-oxazolidin-3-yl]-2,2'-difluoro-biphenyl-4-yl}-2-oxo-oxazolidin-5-ylmethyl)-acetamide, used for treating a bacterial infections in mammals |
| 05/19/2005 | DE10348023A1 Neue Alanyl-Aminopeptidasen-Inhibitoren zur funktionellen Beeinflussung unterschiedlicher Zellen und zur Behandlung immunologischer, entzündlicher, neuronaler und anderer Erkrankungen New alanyl aminopeptidase inhibitors for functional interference of different cells and for the treatment of immunological, inflammatory, neuronal and other diseases |
| 05/19/2005 | CA2545119A1 A process for the manufacture of zonisamide |
| 05/18/2005 | CN1617852A Alpha-(n-sulphonamido)acetamide derivatives as beta-amyloid inhibitors |
| 05/18/2005 | CN1617850A Dibenzylamine compound and medicinal use thereof |
| 05/17/2005 | US6893650 Fungicides; locus infestation; such as N,N-dimethyl-N'-(4-(3-trifluoromethylbenzylthio)-2,5-xylyl)formamidine |
| 05/12/2005 | WO2005042513A1 Phenyl carboxamide and sulfonamide derivatives for use as 11-beta-hydroxysteroid dehydrogenase |
| 05/12/2005 | WO2005041959A1 Phenoxyacetic acids derivatives useful as peroxisome proliferator-activated receptor (ppar) dual agonists |
| 05/12/2005 | WO2005007635A8 Combretastatin derivatives with cytotoxic action |
| 05/12/2005 | WO2003006454A8 Heterocyclic carboxamides and their use as fungicides |
| 05/12/2005 | CA2544317A1 Phenoxyacetic acids derivatives useful as peroxisome proliferator-activated receptor (ppar) dual agonists |
| 05/12/2005 | CA2540843A1 Phenyl carboxamide and sulfonamide derivatives for use as 11-beta-hydroxysteroid dehydrogenase |
| 05/11/2005 | EP1529530A1 Compounds affecting glucokinase |
| 05/11/2005 | EP1056341A4 Method and apparatus for the preparation of ketones |
| 05/11/2005 | EP0951464B1 N-(aryl/heteroarylacetyl) amino acid esters, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds |
| 05/11/2005 | CN1615305A Coumarin derivatives, process for their production and use thereof |
| 05/11/2005 | CN1613853A PDF enzyme inhibitor-hydroxamic acid serial compounds synthetic method and use thereof |
| 05/10/2005 | US6890956 Cyclohexyl sulphones as gamma-secretase inhibitors |
| 05/10/2005 | US6890942 Acyl sulfonamides as inhibitors of HIV integrase |
| 05/06/2005 | WO2005040161A1 Biaryl linked hydroxamates: preparation and pharmaceutical applications |
| 05/06/2005 | WO2005040142A1 Novel keto-oxadiazole derivatives as cathepsin inhibitors |
| 05/06/2005 | WO2005040138A1 Substituted benzylaminoalkylene heterocycles |
| 05/06/2005 | WO2005040121A2 Amides that inhibit vanilloid receptor subtype 1 (vr1) receptor |
| 05/06/2005 | WO2005040100A1 Tetrahydro-naphthalene and urea derivatives |
| 05/06/2005 | CA2542695A1 Substituted benzylaminoalkylene heterocycles |
| 05/06/2005 | CA2542494A1 Tetrahydro-naphthalene and urea derivatives |
| 05/06/2005 | CA2539967A1 Amides that inhibit vanilloid receptor subtype 1 (vr1) receptor |
| 05/05/2005 | US20050096362 4-((Phenoxyalkyl)thio)-phenoxyacetic acids and analogs |
| 05/05/2005 | US20050096357 Antibiotics; therapy for infections which is caused by drug-resistant Streptococcus, or bacteria infections |
| 05/04/2005 | EP1528059A2 Substituted isoxazoles for the treatment of inflammation |
| 05/04/2005 | EP1528058A1 Polymorphic crystalline forms of celecoxib |
| 05/04/2005 | EP1528055A2 Sulphonamide Derivatives |
| 05/04/2005 | EP1526895A2 Methods for treating carbonic anhydrase mediated disorders |
| 05/04/2005 | EP1526869A1 Compositions of a cyclooxygenase-2 selective inhibitor and a carbonic anhydrase inhibitor for the treatment of neoplasia |
| 05/04/2005 | EP1373229A4 Process for the preparation of 1,2-benzisoxazole-3-acetic acid |
| 05/03/2005 | US6887905 Treatment of depression or generalized anxiety disorder |
| 05/03/2005 | US6887877 Viricide for hepatitis virus |
| 05/03/2005 | US6887871 Use of phenylheteroakylamine derivatives |
| 05/03/2005 | US6887863 Such as (2RS,3R)-3-amino-4-cyclohexyl-2-hydroxy-N-phenoxybutanamide; methionine aminopeptidase type 2 inhibitors |
| 05/03/2005 | CA2133337C Compounds useful for treating allergic or inflammatory diseases |
| 04/28/2005 | WO2005037271A2 Large conductance calcium-activated k channel opener |
| 04/28/2005 | WO2005037257A2 Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
| 04/28/2005 | WO2004014844A3 Aryl and heteroaryl compounds and methods to modulate coagulation |
| 04/28/2005 | CA2542723A1 Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
| 04/27/2005 | EP1525883A1 Ciclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect |
| 04/27/2005 | EP1525191A2 Novel method for preparing styryl pyrazole, isoxazole and isothiazole derivatives |
| 04/27/2005 | EP1524974A2 Transcription factor modulating compounds and methods of use thereof |
| 04/27/2005 | EP1011651B1 Method of treating diabetes and related disease states |
| 04/27/2005 | CN1610659A Carboxylic acid derivative |
| 04/27/2005 | CN1198838C Antipicornaviral compounds, their prepn. and use |
| 04/26/2005 | US6884821 Alkyloxypropanoic acid derivative containing sulfonamide or amide group are useful as insulin resistance agent |
| 04/26/2005 | US6884814 Phenyl benzisoxazoles as estrogenic agents |
| 04/26/2005 | CA2213124C Benzoyl derivatives |
| 04/21/2005 | WO2005035514A2 Modulators of atp-binding cassette transporters containing cycloalkyl or pyranyl groups |
| 04/21/2005 | WO2005035510A1 Derivatives of 4-phenylthiazoles and 4-phenylimidazoles and the use thereof as medicaments for treating neurodegenerative diseases, pain and epilepsy |
| 04/21/2005 | WO2005034848A2 Inhibitors of cathepsin s |
| 04/21/2005 | WO2004111019A3 Protective groups cleavable by serumal albumins |
| 04/21/2005 | US20050085667 N-biphenylmethyl aminocycloalkanecarboxamide derivatives |